• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
FCT
Click for more information
0.23% $21.85

F&C Investment Trust PLC Ordinary Shares

watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
FCT
Ann: Net Asset Value as at 18 September 2024 		20/09/24 0 37
20/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  37 
FCT
Ann: Transaction in Own Shares 		20/09/24 0 34
20/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  34 
FCT
Ann: Net Asset Value as at 17 September 2024 		19/09/24 0 31
19/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  31 
FCT
Ann: Transaction in Own Shares 		19/09/24 0 33
19/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  33 
FCT
Ann: Net Asset Value 16 September 2024 		18/09/24 0 44
18/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  44 
FCT
Ann: Transaction in Own Shares 		18/09/24 0 46
18/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  46 
FCT
Ann: Net asset value as at 13 September 2024 		17/09/24 0 38
17/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  38 
FCT
Ann: Share Buyback 		17/09/24 0 32
17/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  32 

See All Discussions arrow Created with Sketch.

Featured News

NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
(20min delay)
Last
$21.85 		Change
0.050(0.23%) 		Mkt cap ! n/a
Open High Low Value Volume
$21.99 $21.99 $21.85 $33.62K 1.537K

Buyers (Bids)

No. Vol. Price($)
0 300 $21.80
 

Sellers (Offers)

Price($) Vol. No.
$21.99 1522 0
Last trade - 09.17am 20/09/2024 (20 minute delay) ?
FCT (NZSX) Chart

Top Stories

Develop Global appoints GR to get Woodlawn copper-zinc plant online mid-2025

Develop shares jumped just over 4% in lunchtime trades on Friday as the company sees mid-2025 Woodlawn start.
Sandfire's latest drill run extends known polymetal mineralisation at the Sesmarias Prospect Sandfire Limited (ASX:SFR) has posted evidence of extended mineralisation at its Portugese Sesmarias Prospect.
ASX Market Open: Aussie stocks follow US surge after Fed rate cut decision | September 20, 2024 Australia's stock market is set to open higher today, following record performances on Wall Street, following the Federal Reserve's rate cut
Westar wraps up field campaign at Mindoolah after divesting non-core assets ahead of 2025 Westar Resources (ASX:WSR) has wrapped up a field campaign on-site its Mindoolah Mining Centre project in WA.
Week 38 Wrap: US markets panic at 50bp cut; ALS’s minerals revenue  slowdown; RBA path unclear Well, it finally happened – the US Fed cut interest rates this week, and we got a double dose: a whole -50bps knocked off.

Featured News

EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.